685 related articles for article (PubMed ID: 29803541)
21. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
22. APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points.
Toledo JB; Habes M; Sotiras A; Bjerke M; Fan Y; Weiner MW; Shaw LM; Davatzikos C; Trojanowski JQ;
J Alzheimers Dis; 2019; 69(3):783-793. PubMed ID: 31127775
[TBL] [Abstract][Full Text] [Related]
23. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
[TBL] [Abstract][Full Text] [Related]
24. Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease.
Nyarko JNK; Quartey MO; Pennington PR; Heistad RM; Dea D; Poirier J; Baker GB; Mousseau DD
Neuroscience; 2018 Mar; 373():20-36. PubMed ID: 29331531
[TBL] [Abstract][Full Text] [Related]
25. Sex Mediates Relationships Between Regional Tau Pathology and Cognitive Decline.
Buckley RF; Scott MR; Jacobs HIL; Schultz AP; Properzi MJ; Amariglio RE; Hohman TJ; Mayblyum DV; Rubinstein ZB; Manning L; Hanseeuw BJ; Mormino EC; Rentz DM; Johnson KA; Sperling RA
Ann Neurol; 2020 Nov; 88(5):921-932. PubMed ID: 32799367
[TBL] [Abstract][Full Text] [Related]
26. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.
Donohue MC; Sperling RA; Salmon DP; Rentz DM; Raman R; Thomas RG; Weiner M; Aisen PS; ; ;
JAMA Neurol; 2014 Aug; 71(8):961-70. PubMed ID: 24886908
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein E ε4 and ε3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-β in mild cognitive impairment but not in Alzheimer's disease.
Xing F; Meng T; Therriault J; Luo J; Zhang H;
J Integr Neurosci; 2021 Jun; 20(2):277-286. PubMed ID: 34258926
[TBL] [Abstract][Full Text] [Related]
28. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
29. Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults.
Buckley RF; Mormino EC; Rabin JS; Hohman TJ; Landau S; Hanseeuw BJ; Jacobs HIL; Papp KV; Amariglio RE; Properzi MJ; Schultz AP; Kirn D; Scott MR; Hedden T; Farrell M; Price J; Chhatwal J; Rentz DM; Villemagne VL; Johnson KA; Sperling RA
JAMA Neurol; 2019 May; 76(5):542-551. PubMed ID: 30715078
[TBL] [Abstract][Full Text] [Related]
30. Discordant amyloid-β PET and CSF biomarkers and its clinical consequences.
de Wilde A; Reimand J; Teunissen CE; Zwan M; Windhorst AD; Boellaard R; van der Flier WM; Scheltens P; van Berckel BNM; Bouwman F; Ossenkoppele R
Alzheimers Res Ther; 2019 Sep; 11(1):78. PubMed ID: 31511058
[TBL] [Abstract][Full Text] [Related]
31. Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β.
Mormino EC; Papp KV; Rentz DM; Donohue MC; Amariglio R; Quiroz YT; Chhatwal J; Marshall GA; Donovan N; Jackson J; Gatchel JR; Hanseeuw BJ; Schultz AP; Aisen PS; Johnson KA; Sperling RA
Alzheimers Dement; 2017 Sep; 13(9):1004-1012. PubMed ID: 28253478
[TBL] [Abstract][Full Text] [Related]
32. Inter-network connectivity and amyloid-beta linked to cognitive decline in preclinical Alzheimer's disease: a longitudinal cohort study.
Van Hooren RWE; Riphagen JM; Jacobs HIL;
Alzheimers Res Ther; 2018 Aug; 10(1):88. PubMed ID: 30153858
[TBL] [Abstract][Full Text] [Related]
33. Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer's disease: a cohort study.
Mattsson N; Ossenkoppele R; Smith R; Strandberg O; Ohlsson T; Jögi J; Palmqvist S; Stomrud E; Hansson O
Alzheimers Res Ther; 2018 Aug; 10(1):77. PubMed ID: 30086796
[TBL] [Abstract][Full Text] [Related]
34. Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months.
Thai C; Lim YY; Villemagne VL; Laws SM; Ames D; Ellis KA; Rainey-Smith SR; Martins RN; Masters CL; Rowe CC; Maruff P;
PLoS One; 2015; 10(10):e0139082. PubMed ID: 26430784
[TBL] [Abstract][Full Text] [Related]
35. Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.
Chung JK; Plitman E; Nakajima S; Caravaggio F; Iwata Y; Gerretsen P; Kim J; Takeuchi H; Shinagawa S; Patel R; Chakravarty MM; Graff-Guerrero A;
J Alzheimers Dis; 2017; 58(3):747-762. PubMed ID: 28505977
[TBL] [Abstract][Full Text] [Related]
36. Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease.
Huang SY; Zhang YR; Guo Y; Du J; Ren P; Wu BS; Feng JF; ; Cheng W; Yu JT
Alzheimers Dement; 2024 May; 20(5):3251-3269. PubMed ID: 38501315
[TBL] [Abstract][Full Text] [Related]
37. Capillary dysfunction in healthy elderly APOE ε4 carriers with raised brain Aβ deposition.
Madsen LS; Kjeldsen PL; Ismail R; Parbo P; Østergaard L; Brooks DJ; Eskildsen SF
Alzheimers Dement; 2024 Jan; 20(1):459-471. PubMed ID: 37679610
[TBL] [Abstract][Full Text] [Related]
38. An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele.
Shahid M; Kim J; Leaver K; Hendershott T; Zhu D; Cholerton B; Henderson VW; Tian L; Poston KL
Neurobiol Dis; 2019 Jul; 127():278-286. PubMed ID: 30826425
[TBL] [Abstract][Full Text] [Related]
39. APOE effects on regional tau in preclinical Alzheimer's disease.
Young CB; Johns E; Kennedy G; Belloy ME; Insel PS; Greicius MD; Sperling RA; Johnson KA; Poston KL; Mormino EC; ;
Mol Neurodegener; 2023 Jan; 18(1):1. PubMed ID: 36597122
[TBL] [Abstract][Full Text] [Related]
40. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
